TTK Healthcare Limited

NSEI:TTKHLTCARE Stock Report

Market Cap: ₹18.6b

TTK Healthcare Past Earnings Performance

Past criteria checks 3/6

TTK Healthcare has been growing earnings at an average annual rate of 28.6%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 5.3% per year. TTK Healthcare's return on equity is 7.7%, and it has net margins of 10.4%.

Key information

28.6%

Earnings growth rate

28.6%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate5.3%
Return on equity7.7%
Net Margin10.4%
Next Earnings Update24 Jan 2025

Recent past performance updates

Recent updates

TTK Healthcare (NSE:TTKHLTCARE) Has Affirmed Its Dividend Of ₹10.00

Jul 16
TTK Healthcare (NSE:TTKHLTCARE) Has Affirmed Its Dividend Of ₹10.00

TTK Healthcare (NSE:TTKHLTCARE) Is Paying Out A Dividend Of ₹10.00

Jul 02
TTK Healthcare (NSE:TTKHLTCARE) Is Paying Out A Dividend Of ₹10.00

Estimating The Fair Value Of TTK Healthcare Limited (NSE:TTKHLTCARE)

Mar 04
Estimating The Fair Value Of TTK Healthcare Limited (NSE:TTKHLTCARE)

Is Now The Time To Put TTK Healthcare (NSE:TTKHLTCARE) On Your Watchlist?

Jun 04
Is Now The Time To Put TTK Healthcare (NSE:TTKHLTCARE) On Your Watchlist?

Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?

Mar 17
Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?

Here's Why TTK Healthcare (NSE:TTKHLTCARE) Can Manage Its Debt Responsibly

Feb 22
Here's Why TTK Healthcare (NSE:TTKHLTCARE) Can Manage Its Debt Responsibly

TTK Healthcare Limited (NSE:TTKHLTCARE) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Feb 02
TTK Healthcare Limited (NSE:TTKHLTCARE) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

A Look At TTK Healthcare's (NSE:TTKHLTCARE) Share Price Returns

Jan 19
A Look At TTK Healthcare's (NSE:TTKHLTCARE) Share Price Returns

Our Take On TTK Healthcare's (NSE:TTKHLTCARE) CEO Salary

Jan 01
Our Take On TTK Healthcare's (NSE:TTKHLTCARE) CEO Salary

Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?

Dec 16
Is TTK Healthcare Limited (NSE:TTKHLTCARE) A Good Fit For Your Dividend Portfolio?

Is There More To The Story Than TTK Healthcare's (NSE:TTKHLTCARE) Earnings Growth?

Dec 01
Is There More To The Story Than TTK Healthcare's (NSE:TTKHLTCARE) Earnings Growth?

Is TTK Healthcare (NSE:TTKHLTCARE) A Risky Investment?

Nov 16
Is TTK Healthcare (NSE:TTKHLTCARE) A Risky Investment?

Is The Market Rewarding TTK Healthcare Limited (NSE:TTKHLTCARE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

Oct 21
Is The Market Rewarding TTK Healthcare Limited (NSE:TTKHLTCARE) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

How Is TTK Healthcare's (NSE:TTKHLTCARE) CEO Paid Relative To Peers?

Sep 21
How Is TTK Healthcare's (NSE:TTKHLTCARE) CEO Paid Relative To Peers?

Do These 3 Checks Before Buying TTK Healthcare Limited (NSE:TTKHLTCARE) For Its Upcoming Dividend

Aug 29
Do These 3 Checks Before Buying TTK Healthcare Limited (NSE:TTKHLTCARE) For Its Upcoming Dividend

TTK Healthcare's (NSE:TTKHLTCARE) Shareholders Are Down 36% On Their Shares

Aug 21
TTK Healthcare's (NSE:TTKHLTCARE) Shareholders Are Down 36% On Their Shares

Are Dividend Investors Getting More Than They Bargained For With TTK Healthcare Limited's (NSE:TTKHLTCARE) Dividend?

Jul 24
Are Dividend Investors Getting More Than They Bargained For With TTK Healthcare Limited's (NSE:TTKHLTCARE) Dividend?

Revenue & Expenses Breakdown

How TTK Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NSEI:TTKHLTCARE Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 247,7137992,5710
30 Jun 247,5867872,5330
31 Mar 247,5286282,4930
31 Dec 237,5196502,3210
30 Sep 237,5066412,3200
30 Jun 237,3465602,2950
31 Mar 237,2514472,2720
31 Dec 227,0362852,1860
30 Sep 226,7982262,1160
30 Jun 226,6051852,0310
31 Mar 225,9921851,9540
31 Dec 217,7094132,4980
30 Sep 217,3763682,4680
30 Jun 216,9095482,4830
31 Mar 214,7613681,6590
31 Dec 205,9183652,3920
30 Sep 205,7843332,3530
30 Jun 205,836631,4210
31 Mar 206,4581232,3550
31 Dec 196,4891691,4470
30 Sep 196,3211731,3890
30 Jun 196,3332011,3440
31 Mar 196,2792441,3080
31 Dec 186,3342742,0130
30 Sep 186,3133481,9200
30 Jun 186,2073931,8950
31 Mar 185,7751821,8890
31 Dec 175,5411581,7670
30 Sep 175,1261261,6160
30 Jun 175,054938930
31 Mar 175,2781871,5430
31 Dec 165,3601971,6290
30 Sep 165,3992341,6460
30 Jun 165,3342361,6340
31 Mar 165,1892271,6060
31 Dec 155,0792132,2430
30 Sep 155,0121822,2280
30 Jun 154,9181732,2090
31 Mar 154,8291621,5390
31 Dec 144,7161482,1010
30 Sep 144,5651412,0380
30 Jun 144,3681401,9490
31 Mar 144,1621241,8720

Quality Earnings: TTKHLTCARE has a high level of non-cash earnings.

Growing Profit Margin: TTKHLTCARE's current net profit margins (10.4%) are higher than last year (8.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: TTKHLTCARE's earnings have grown significantly by 28.6% per year over the past 5 years.

Accelerating Growth: TTKHLTCARE's earnings growth over the past year (24.7%) is below its 5-year average (28.6% per year).

Earnings vs Industry: TTKHLTCARE earnings growth over the past year (24.7%) exceeded the Pharmaceuticals industry 20.5%.

Return on Equity

High ROE: TTKHLTCARE's Return on Equity (7.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 19:20
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TTK Healthcare Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research